Skip to main content
SpringerLink
Log in

Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Myocardial infarction is the most common cause of congestive cardiac failure. Free radicals, cytokines, nitric oxide (NO) and antioxidants play a major role both in atherosclerosis and myocardial damage and preservation. In the early stages of atherosclerosis, neutrophils and monocytes infiltrate the intima and generate free radicals which damage the endothelial cells. As a result, production of NO and prostacyclin by the endothelial cells declines, which have cardioprotective actions. This also has relevance to the beneficial action of aspirin since, it can modulate both prostanoid and l-arginine-NO systems and NF-kB translocation. In both acute myocardial infarction and chronic congestive cardiac failure, the plasma levels of various inflammatory mediators such as interleukins and tumour necrosis factor-α (TNFα) are elevated. TNFα, produced by the inflammatory cells and the myocardium, can suppress myocardial contractility and induce the production of free radicals, which in turn can further damage the myocardium. Transforming growth factor β (TGFβ), polyunsaturated fatty acids and the glucose-insulin-potassium regimen can antagonize the harmful actions of TNFα and protect the myocardium. This explains why efforts made to reduce the levels of pro-inflammatory cytokines have beneficial action and preserve the myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Das UN: Can free radicals cause acute myocardial infarction? Med Hypotheses 39: 90–94, 1992

    Google Scholar 

  2. Ross S: Atherosclerosis–an inflammatory disease. N Engl J Med 340: 115–126, 1999

    Google Scholar 

  3. Das UN: Transforming growth factor-beta: Is it an endogenous carioprotector? Med Sci Res 21: 373–375, 1993

    Google Scholar 

  4. Laight DW, Kaw AV, Carrier MJ, Anggard EE: Interaction between superoxide anion and nitric oxide in the regulation of vascular endothelial function. Br J Pharmacol 124: 238–244, 1998

    Google Scholar 

  5. Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S: Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of ischemic heart disease. J Am Med Assoc 281: 1722–1727, 1999

    Google Scholar 

  6. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, Hori M: Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 189: 1699–1706, 1999

    Google Scholar 

  7. Wang XL, Adachi T, Sim AS, Wilcken DE: Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol 18: 1915–1921, 1998

    Google Scholar 

  8. Tripathi Y, Hegde BM: Effect of alpha-tocopherol pretreatment on infarct size following 90 minutes of ischemia and 4 hours of reperfusion in dogs. Ind J Physiol Pharmacol 41: 241–247, 1997

    Google Scholar 

  9. Yamamoto T, Cohen AM, Kakar NR, Yamamoto M, Johnson PE, Cho YK et al.: Production of prostanoids and nitric oxide by infracted heart in situ and the effect of aspirin. Biochem Biophys Res Commun 257: 488–493, 1999

    Google Scholar 

  10. Kimura A, Roseto J, Suh KY, Cohen AM, Bing RJ: Effect of acetylsalicylic acid on nitric oxide production in infarcted heart in situ. Biochem Biophys Res Commun 251: 874–878, 1998

    Google Scholar 

  11. Aitchison KA, Coker SJ: Cyclooxygenase inhibition converts the effect of nitric oxide synthase inhibition from infarct size reduction to expansion isolated rabbit hearts. J Mol Cell Cardiol 31: 1315–1324, 1999

    Google Scholar 

  12. Amberger A, Hala M, Saurwein-Teissl M, Metzler B, Grubeck-Loebenstein B, Xu Q et al.: Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins. Mol Med 5: 117–128, 1999

    Google Scholar 

  13. Shi X, Ding M, Dong Z, Chen F, Ye J, Wang S et al.: Antioxidant properties of aspirin: Characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-kappaB activation, and TNF-alpha production. Mol Cell Biochem 199: 93–102, 1999

    Google Scholar 

  14. Sanchez de Miguel L, de Frutos T, Gonzalez-Fernandez F, del Pozo V, Lahoz C, Jimenez A et al.: Aspirin inhibits inducible nitric oxide synthase expression and tumour necrosis factor-alpha release by cultured smooth muscle cells. Eur J Clin Invest 29: 93–99, 1999

    Google Scholar 

  15. Shackelford RE, Alford PB, Xue Y, Tahi SF, Adams DO, Pizzo S: Aspirin inhibits tumor necrosis factor alpha gene expression in murine tissue macrophages. Mol Pharmacol 52: 421–429, 1997

    Google Scholar 

  16. Osnes LT, Foss KB, Joo GB, Okkenhaug C, Westvik AB, Ovstebo R, Kierulf P: Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes. Thromb Haemost 76: 970–976, 1996

    Google Scholar 

  17. Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science265: 956–959, 1994

    Google Scholar 

  18. Squadrito F, Altavilla D, Squadrito G, Saitta A, Campo GM, Arlotta M et al.: Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats. Eur J Pharmacol 364: 159–168, 1999

    Google Scholar 

  19. Ott I, Neumann FJ, Kenngott S, Gawaz M, Schomig A: Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol 82: 938–942, 1998

    Google Scholar 

  20. Ozmen D, Boydak B, Mutaf I, Zoghi M, Kumanlioglu K, Guner I et al.: The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction. Jpn Heart J 40: 267–273, 1999

    Google Scholar 

  21. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd' Heuil D, et al.: Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 276: H1567–1573, 1999

    Google Scholar 

  22. Wang D, Yang XP, Liu YH, Carretero OA, LaPointe MC: Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. Am J Hypertens 12: 174–182, 1999

    Google Scholar 

  23. Xi L, Jarrett NC, Hess ML, Kukreja RC: Myocardial ischemia/reperfusion injury in the inducible nitric oxide synthase knockout mice. Life Sci 65: 935–945, 1999

    Google Scholar 

  24. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, Ertl G: Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide production. Circulation 100: 292–298, 1999

    Google Scholar 

  25. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A et al.: A common variant of the endothelial nitric oxide synthase (Glu(298) → Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100: 1515–1520, 1999

    Google Scholar 

  26. Blann AD, McCollum CN: Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: No clear relationship with levels of tumor necrosis factor. Inflammation 22: 483–491, 1998

    Google Scholar 

  27. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH et al.: Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99: 546–551, 1999

    Google Scholar 

  28. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A et al.: Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99: 1492–1498, 1999

    Google Scholar 

  29. Das UN, Padma M, Sagar PS, Ramesh G, Koratkar R: Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent process. Biochem Biophys Res Commun 167: 1030–1036, 1990

    Google Scholar 

  30. Newman WH, Zunzunegui RG, Warejcka DJ, Dalton ML, Castresana MR: A reactive oxygen-generating system activates nuclear factorkappa B and releases tumor necrosis factor-alpha in coronary smooth muscle cells. J Surg Res 85: 142–147, 1999

    Google Scholar 

  31. Meldrum DR and Donnahoo KK: Role of TNF in mediating renal insufficiency following cardiac surgery: Evidence of a postbypass cardiorenal syndrome. J Surg Res 85: 185–199, 1999

    Google Scholar 

  32. Samad F, Uysal KT, Wiesbrock SM, Pandey M, Hotamisligil GS, Loskutoff DJ: Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci USA 96: 6902–6907, 1999

    Google Scholar 

  33. Das UN: GLUT-4, tumor necrosis factor, essential fatty acids, daf-genes and their role in insulin resistance and non-insulin dependent diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 60: 13–20, 1999

    Google Scholar 

  34. Hotamisligil GS: The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245: 621–625, 1999

    Google Scholar 

  35. Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in congestive heart failure. N Engl J Med 323: 236–241, 1990

    Google Scholar 

  36. Cain BS, Harken AH, Meldrum DR: Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion. J Mol Cell Cardiol 31: 931–947, 1999

    Google Scholar 

  37. Li D, Zhao L, Liu M, Du X, Ding W, Zhang J, Mehta JL: Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J 137: 1145–1152, 1999

    Google Scholar 

  38. Das UN: Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukot Essent Fatty Acids61: 157–164, 1999

    Google Scholar 

  39. Ferrari R: Tumor necrosis factor in CHF: A double facet cytokine. Cardiovasc Res 37: 554–559, 1998

    Google Scholar 

  40. Feng Q, Lu X, Fortin AJ, Petterson A, Hedner T, Kline RL, Arnold JM: Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. Cardiovasc Res 37: 667–675, 1998

    Google Scholar 

  41. Lefer AM, Tsao P, Aoki N, Palladino MA Jr: Mediation of cardioprotection by transforming growth factor-beta. Science 249:61–64, 1990

    Google Scholar 

  42. Sawdey MS and Loskutoff DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88: 1346–1353, 1991

    Google Scholar 

  43. Lefer AM, Ma XL, Weyrich AS, Scalia R: Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc Natl Acad Sci USA 90: 1018–1022, 1993

    Google Scholar 

  44. Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK et al.: Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83: 376–382, 1999

    Google Scholar 

  45. Nozaki N, Yamaguchi S, Yamaoka M, Okuyama M, Nakamura H, Tomoike H: Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure. J Mol Cell Cardiol 30: 2003–2012, 1998

    Google Scholar 

  46. Yamaoka M, Y amaguchi S, Okuyama M, Tomoike H: Anti-inflammatory cytokine profile in human heart failure: Behavior of interleukin-10 in association with tumor necrosis factor-alpha. Jpn Circ J 63: 951–956, 1999

    Google Scholar 

  47. Endres S, Ghorbani R, Kelley V E, Georgilis K, Lonnemann G, van der Meer JW et al.: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320: 265–271, 1989

    Google Scholar 

  48. Kumar GS, Das UN: Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various cytokines. Prostaglandins Leukot Essent Fatty Acids 50: 331–334, 1994

    Google Scholar 

  49. Das UN: Beneficial effect of eicosapentaenoic and docosahexaenoic acids in the management of systemic lupus erythematosus and its relationship to the cytokine net work. Prostaglandins Leukot Essent Fatty Acids 51: 207–213, 1994

    Google Scholar 

  50. Fernandes G, Bysani C, Venkataraman JT, Tomar V, Zhao W: Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 152: 5979–5987, 1994

    Google Scholar 

  51. Sethi S, Eastman AY, Eaton JW: Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: A natural anti-inflammatory mechanism? J Lab Clin Med 128: 27–38, 1996

    Google Scholar 

  52. GISSI-Prevention Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 354: 447–455, 1999

    Google Scholar 

  53. Freeman LM, Rush JE, Kehayias JJ, Ross Jr, Meydani SN, Brown DJ et al.: Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med 12: 440–448, 1998

    Google Scholar 

  54. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF et al.: 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 100: 1016–1030, 1999

    Google Scholar 

  55. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF et al.: 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34: 890–911, 1999

    Google Scholar 

  56. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R et al.: Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 98: 2227–2234, 1998

    Google Scholar 

  57. Fath-Ordoubadi F, Beatt KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 96: 1152–1156, 1997

    Google Scholar 

  58. Rogers WJ, Stanley AW Jr, Breinig JB, Prather JW, McDaniel HG, Moraski RE et al.: Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J 92: 441–454, 1976

    Google Scholar 

  59. Das UN: Possible beneficial action(s) of glucose-insulin-potassium regimen in acute myocardial infarction and inflammatory conditions: A hypothesis. Diabetologia, in press

  60. Fraker DL, Merino MJ, Norton JA: Reversal of the toxic effects of cachectin by concurrent insulin administration. Am J Physiol 256: E725–E731, 1989.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. EFA Sciences LLC, Providence Highway, Suite ~ 266, Norwood, MA, 02062, USA

    U.N. Das

Authors
  1. U.N. Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Das, U. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 215, 145–152 (2000). https://doi.org/10.1023/A:1026579422132

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026579422132

Search

Navigation